• Company
• Imfinzi for liver cancer is expected to land in Korea soon
• by Eo, Yun-Ho May 30, 2023 05:33am

• Company
• Reimb in progress for 1st endometrial cancer immunotherapy
• by Jung, Sae-Im May 30, 2023 05:33am

• Company
• Ebixa 20mg may be prescribed at general hospitals in Korea
• by Eo, Yun-Ho May 26, 2023 06:47am

• Company
• Lucentis sales fell 34%
• by Chon, Seung-Hyun May 26, 2023 06:47am

• Company
• Shingles vaccine Shingrix occupies 29% of market in 3 months
• by Jung, Sae-Im May 26, 2023 06:47am

• Policy
• "Nurturing biopharmaceuticals as the second semiconductor"
• by Kang, Shin-Kook May 25, 2023 11:05pm

• Policy
• Welireg·Camzyos are approved in Korea
• by Lee, Hye-Kyung May 25, 2023 05:46am

• Company
• BMS’s oHCM drug Camzyos approved in Korea
• by Jung, Sae-Im May 25, 2023 05:46am

• Company
• Latecomer new CML drug Bosulif attempts reimb in Korea
• by Eo, Yun-Ho May 25, 2023 05:46am

• Company
• Seven times stricter standards
• by Chon, Seung-Hyun May 25, 2023 05:46am